Skip to content

HONEYPATCH

Active
Private limited companyfounded 2013active for 13 yearsQuai Banning 6, 4000 Liège, Belgium54 active companies are registered at this addressKBO/BCE: BE 0524.896.791
Summary

The computed 12-month bankruptcy probability of HONEYPATCH is 3.8% (moderate). The 2024 annual accounts show negative equity (-€388,117) and a net result of -€144,190. Equity is shrinking by about 14% per year across the filed financial years. Its solvency ranks better than 14% of 86 sector peers (NACE 21, financial year 2024). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21209Wholesale of pharmaceutical and medical goods NACE 46460
8th oldest company in the province of Liège, Pharmaceuticals sector1 site
Size
€330,409total assets 2024
Staff
3.5 FTE
Equity
-€388,117
Loss
-€144,190
Financial health
47 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
3.8%
Structure
2025 accounts not filed, 86 days past the deadline1 of 4 deeds summarised
Why 47raises riskLoss of €144,190, the second in a row (financial year 2024)1 financial year not filed after the legal deadline; last filed accounts filed 61 days late; 2 of the last 3 latelowers riskSize: total assets €330,409Founded in 2013Show the evidence

Checked score

Score 2024
47 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 16% of its sector peers (NACE 21, micro)
Financial strength · tick = 2023
Weak
Solvency 0=
equity -117.5% of total assets
Liquidity 29-18
short-term debt 52.3% · cash 4.0%
Profitability 0-22
return on assets -43.6%
Bankruptcy probability, 12 months
3.8% Moderate
0%0.5%1.5%4%10%≥ 25%

About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (154 companies, NACE 21, micro)
Last 24 months 11-2024: 5.3% 12-2024: 6.2%▲ +0.9 percentage points vs 11-2024 01-2025: 6.3%▲ +0.1 percentage points vs 12-2024 02-2025: 6.3%● unchanged vs 01-2025 03-2025: 6.1%▼ -0.2 percentage points vs 02-2025 04-2025: 6.3%▲ +0.2 percentage points vs 03-2025 05-2025: 6.3%● unchanged vs 04-2025 06-2025: 6.0%▼ -0.3 percentage points vs 05-2025 07-2025: 6.1%▲ +0.1 percentage points vs 06-2025 08-2025: 5.9%▼ -0.2 percentage points vs 07-2025 09-2025: 6.1%▲ +0.2 percentage points vs 08-2025 10-2025: 7.3%▲ +1.2 percentage points vs 09-2025highest value 11-2025: 6.3%▼ -1.0 percentage point vs 10-2025 12-2025: 6.3%● unchanged vs 11-2025 01-2026: 6.3%● unchanged vs 12-2025 02-2026: 6.3%● unchanged vs 01-2026 03-2026: 6.1%▼ -0.2 percentage points vs 02-2026 04-2026: 6.2%▲ +0.1 percentage points vs 03-2026 05-2026: 6.2%● unchanged vs 04-2026 06-2026: 6.0%▼ -0.2 percentage points vs 05-2026 07-2026: 6.0%● unchanged vs 06-2026 08-2026: 6.0%● unchanged vs 07-2026 09-2026: 6.2%▲ +0.2 percentage points vs 08-2026 10-2026: 3.8%▼ -2.4 percentage points vs 09-2026lowest value
No credit on open account
Liquidity insufficient (current ratio 0.85, compared with 2.02 in 2023, below 1; short-term debt: 52.3% and cash: 4% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro): better than 10% on solvency, 27% on liquidity, 13% on profitability and 14% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises risk
raises risk · Loss of €144,190, the second in a row (financial year 2024)
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; last filed accounts filed 61 days late; 2 of the last 3 late
NBB · filings
lowers risk · Size: total assets €330,409
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 2013
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
18192021222324
2018 to 2024 · latest year -€388,117
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 86 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline25-10-2026 today
raises risk · 2024 accounts filed 61 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
61 days late
2023
112 days late
2022
11 days late
2021
61 days late
2020
31 days late
2019
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 50 days after the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Weakest financial yearnet -€144,190
  3. Annual accounts filedfinancial year 2023 · micro…

Financials · financial year 2024, micro format

2025 annual accounts not yet filed, deadline passed on 31 July 2026 Financial year closed on 31 December 2025; filing due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 26 October 2026.

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€144,190▼ 278%
2023 · -€38,177
Working capital
-€25,452
2023 · €100,958
Trend over the years

2020 to 2024, 5 financial years 2018 to 2024, 7 financial years

The operating result stays negative: a loss of €123,418 in 2024 against €23,227 in 2023; the loss grows and 2024 has the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€123,418 2024 Net result-€144,190 2024

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2018201920202021202220232024
Operating result-€110,989--€46,893▲ 57.7%-€61,951▼ 32.1%-€8,989▲ 85.5%-€4,406▲ 51.0%-€23,227▼ 427%-€123,418▼ 431%
Net result-€113,808--€55,002▲ 51.7%-€71,741below the sector's middle half▼ 30.4%-€15,722within the sector's middle half▲ 78.1%-€10,976within the sector's middle half▲ 30.2%-€38,177below the sector's middle half▼ 248%-€144,190below the sector's middle half▼ 278%
Equity-€103,751--€158,753▼ 53.0%-€180,094below the sector's middle half▼ 13.4%-€195,816below the sector's middle half▼ 8.7%-€206,792below the sector's middle half▼ 5.6%-€243,926below the sector's middle half▼ 18.0%-€388,117below the sector's middle half▼ 59.1%
Total assets€358,477-€359,889▲ 0.4%€356,905below the sector's middle half▼ 0.8%€371,156within the sector's middle half▲ 4.0%€392,197within the sector's middle half▲ 5.7%€430,128within the sector's middle half▲ 9.7%€330,409within the sector's middle half▼ 23.2%
Debt€462,228-€518,642▲ 12.2%€536,998▲ 3.5%€566,972▲ 5.6%€598,989▲ 5.6%€674,054▲ 12.5%€718,526▲ 6.6%
Working capital€52,875-€35,900▼ 32.1%€49,139within the sector's middle half▲ 36.9%€11,588within the sector's middle half▼ 76.4%-€6,787within the sector's middle half€100,958within the sector's middle half-€25,452below the sector's middle half
Solvency-28.9%--44.1%▼ 15.2pp-50.5%below the sector's middle half▼ 6.3pp-52.8%below the sector's middle half▼ 2.3pp-52.7%below the sector's middle half=-56.7%below the sector's middle half▼ 4.0pp-117.5%below the sector's middle half▼ 60.8pp
Current ratio1.44-1.40▼ 0.041.80within the sector's middle half▲ 0.401.13within the sector's middle half▼ 0.680.95within the sector's middle half▼ 0.182.02within the sector's middle half▲ 1.070.85within the sector's middle half▼ 1.17
Return on assets (ROA)-31.7%--15.3%▲ 16.5pp-20.1%below the sector's middle half▼ 4.8pp-4.2%within the sector's middle half▲ 15.9pp-2.8%within the sector's middle half▲ 1.4pp-8.9%below the sector's middle half▼ 6.1pp-43.6%below the sector's middle half▼ 34.8pp
Staff (FTE)2-1.8▼ 10.0%1.62▲ 25.0%2.4▲ 20.0%3.5▲ 45.8%
above within below the middle half of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €330,409
Fixed assets €183,151 ▼ 20.4%
Current assets €147,258 ▼ 26.4%
Equity and liabilities
Equity-€388,117
Debt€718,526
Equity is negative: debt (€718,526) exceeds the balance-sheet total (€330,409).
Key figures and ratios
2024 value · change against 2023
EBITDA
-€72,781▼
2023 · €27,278
Cash flow
-€93,554▼
2023 · €12,328
Quick ratio
0.24▼
2023 · 0.82
Interest coverage
-3.50▼
2023 · 1.74
Debt ≤ 1 year
€172,710▲
2023 · €99,054
Debt > 1 year
€545,815▼
2023 · €575,000
Staff costs
€60,859▼
2023 · €79,067
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,906 companies that looked in July 2024 the way this one looks now, 5.8% went bankrupt within 24 months and 85.4% are still going.

  • Micro
  • 10 to 20 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
5.8% went bankrupt
8.2% stopped otherwise
85.4% still going

A further 0.6% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 3.8% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,906 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet Code20232024
Assets
Total assets20/58€430,128€330,409▼
Fixed assets21/28€230,116€183,151▼
Intangible fixed assets21€212,195€170,747▼
Tangible fixed assets22/27€15,310€9,793▼
Plant, machinery and equipment23€137-
Furniture and vehicles24€15,173€9,793▼
Financial fixed assets28€2,611€2,611=
Current assets29/58€200,011€147,258▼
Stocks and contracts in progress3€118,791€105,675▼
Stocks30/36€118,791€105,675▼
Amounts receivable within one year40/41€51,611€14,995▼
Trade receivables40€45,360€14,995▼
Other amounts receivable41€6,252-
Cash at bank and in hand54/58€16,330€13,309▼
Deferred charges and accrued income490/1€13,279€13,279=
Equity and liabilities
Total equity and liabilities10/49€430,128€330,409▼
Equity10/15-€243,926-€388,117▼
Contributions10/11€200,400€200,400=
Profit (loss) carried forward14-€444,326-€588,517▼
Amounts payable17/49€674,054€718,526▲
Amounts payable after more than one year17€575,000€545,815▼
Financial debts170/4€575,000€545,815▼
Amounts payable within one year42/48€99,054€172,710▲
Financial debts43€2,339€9,304▲
Credit institutions430/8€2,339€9,304▲
Trade debts44€4,927€3,667▼
Suppliers440/4€4,927€3,667▼
Taxes, remuneration and social security45€10,734€8,067▼
Taxes450/3€4,578€1,718▼
Remuneration and social security454/9€6,156€6,349▲
Other amounts payable47/48€81,054€151,672▲
Income statement Code20232024
Non-recurring operating income76A-€461
Remuneration, social security and pensions62€79,067€60,859▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€50,505€50,636▲
Other operating charges640/8-€1,248
Non-recurring operating charges66A€7,002€5,558▼
Gross operating margin9900€113,346-€5,116▼
Operating profit (loss)9901-€23,227-€123,418▼
Financial charges65/66B€15,701€20,773▲
Recurring financial charges65€15,701€20,773▲
Profit (loss) for the period before taxes9903-€38,928-€144,190▼
Income taxes67/77-€751-
Profit (loss) for the period9904-€38,177-€144,190▼
Profit (loss) for the period to be appropriated9905-€38,177-€144,190▼
Appropriation of the result
Profit (loss) to be appropriated9906-€444,326-€588,517▼
Profit (loss) brought forward from the previous period14P-€406,150-€444,326▼

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021202220232024Change
Non-recurring operating income76A------€461-
Remuneration, social security and pensions62---€67,505€86,171€79,067€60,859▼ 23.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,484€36,622€38,292€44,446€44,685€50,505€50,636▲ 0.3%
Other operating charges640/8---€1,375€79-€1,248-
Non-recurring operating charges66A-----€7,002€5,558▼ 20.6%
Gross operating margin9900-€27,653€47,126€37,660€104,336€126,529€113,346-€5,116-
Operating profit (loss)9901-€110,989-€46,893-€61,951-€8,989-€4,406-€23,227-€123,418▼ 431%
Recurring financial income75€1€49€48-----
Financial charges65/66B---€6,733€6,570€15,701€20,773▲ 32.3%
Recurring financial charges65€2,620€8,031€9,802€6,733€6,570€15,701€20,773▲ 32.3%
Profit (loss) for the period before taxes9903-€113,608-€54,876-€71,704-€15,722-€10,976-€38,928-€144,190▼ 270%
Income taxes67/77€200€126€37---€751--
Profit (loss) for the period9904-€113,808-€55,002-€71,741-€15,722-€10,976-€38,177-€144,190▼ 278%
Profit (loss) for the period to be appropriated9905-€113,808-€55,002-€71,741-€15,722-€10,976-€38,177-€144,190▼ 278%
Line2018201920202021202220232024Change
Assets
Total assets20/58€358,477€359,889€356,905€371,156€392,197€430,128€330,409▼ 23.2%
Formation expenses20€0-€0-----
Fixed assets21/28€186,374€234,168€246,501€267,597€274,996€230,116€183,151▼ 20.4%
Intangible fixed assets21€167,226€219,160€237,613€261,512€251,326€212,195€170,747▼ 19.5%
Tangible fixed assets22/27€18,888€12,397€6,277€3,474€21,059€15,310€9,793▼ 36.0%
Plant, machinery and equipment23---€873€505€137--
Furniture and vehicles24---€2,601€20,554€15,173€9,793▼ 35.5%
Financial fixed assets28€260€2,611€2,611€2,611€2,611€2,611€2,611=
Current assets29/58€172,103€125,720€110,404€103,559€117,201€200,011€147,258▼ 26.4%
Stocks and contracts in progress3€36,804€78,226€52,356€49,015€61,759€118,791€105,675▼ 11.0%
Stocks30/36---€49,015€61,759€118,791€105,675▼ 11.0%
Amounts receivable within one year40/41€111,709€29,918€33,432€28,332€32,176€51,611€14,995▼ 70.9%
Trade receivables40---€24,816€25,951€45,360€14,995▼ 66.9%
Other amounts receivable41---€3,517€6,225€6,252--
Cash at bank and in hand54/58€15,556-€1€12,933€9,988€16,330€13,309▼ 18.5%
Deferred charges and accrued income490/1---€13,279€13,279€13,279€13,279=
Equity and liabilities
Total equity and liabilities10/49€358,477€359,889€356,905€371,156€392,197€430,128€330,409▼ 23.2%
Equity10/15-€103,751-€158,753-€180,094-€195,816-€206,792-€243,926-€388,117▼ 59.1%
Contributions10/11€150,000€150,000-€200,400€200,400€200,400€200,400=
Profit (loss) carried forward14-€253,751-€308,753-€380,494-€396,216-€407,192-€444,326-€588,517▼ 32.5%
Amounts payable17/49€462,228€518,642€536,998€566,972€598,989€674,054€718,526▲ 6.6%
Amounts payable after more than one year17€343,000€428,000€475,000€475,000€475,000€575,000€545,815▼ 5.1%
Financial debts170/4---€475,000€475,000€575,000€545,815▼ 5.1%
Amounts payable within one year42/48€119,228€89,820€61,265€91,972€123,989€99,054€172,710▲ 74.4%
Financial debts43---€0€5,043€2,339€9,304▲ 298%
Credit institutions430/8----€5,043€2,339€9,304▲ 298%
Trade debts44€112,475€47,809€42,664€29,016€10,882€4,927€3,667▼ 25.6%
Suppliers440/4---€29,016€10,882€4,927€3,667▼ 25.6%
Taxes, remuneration and social security45---€14,566€13,025€10,734€8,067▼ 24.8%
Taxes450/3---€3,245€3,122€4,578€1,718▼ 62.5%
Remuneration and social security454/9---€11,321€9,903€6,156€6,349▲ 3.1%
Other amounts payable47/48---€48,390€95,039€81,054€151,672▲ 87.1%
Line2018201920202021202220232024Change
Profit (loss) for the period9904-€113,808-€55,002-€71,741-€15,722-€10,976-€38,177-€144,190▼ 278%
+ Depreciation and write-downs630€29,484€36,622€38,292€44,446€44,685€50,505€50,636▲ 0.3%
Operating cash flow (approximation)-€84,324-€18,380-€33,449€28,724€33,709€12,328-€93,554-
Investment in fixed assets (approximation)--€84,417-€50,624-€65,542-€52,084-€5,625-€3,671▲ 34.7%
Change in cash---€12,933-€2,946€6,342-€3,021-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 12 filings with the National Bank
Financial year Type Filed Reference
31-12-2024 micro format 30-09-2025 2025-00534424
31-12-2023 micro format 20-11-2024 2024-00602019
31-12-2022 micro format 11-08-2023 2023-00324283
31-12-2021 micro format 30-09-2022 2022-20442891
31-12-2020 full format 31-08-2021 2021-66400243
31-12-2019 full format 25-08-2020 2020-44700069
31-12-2018 full format 16-09-2019 2019-64500275
31-12-2017 full format 22-08-2018 2018-51800490
31-12-2016 full format 04-10-2017 2017-66000564
31-12-2015 full format 04-11-2016 2016-67400192

Show all 12 filings

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 97 active companies whose main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209), figures are known for 75. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
no sitting director read yet, last change in 2024
No directors read yet: 1 of 4 Gazette acts processed. See the directors and other office holders in the KBO →

Mandate history

2 people since 2024, 0 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Emmanuel DESTREE
  • Director, until 19-09-2024
NIZET Jean Luc
  • Director, until 19-09-2024
See the board, name and registered office on a given date →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

HONEYPATCH was incorporated on 27 March 2013.1 The registered office was moved to Liege in 2024.2 Total assets went from €358,477 in 2018 to €330,409 in 2024 and headcount from 2 to 3.5 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 19-09-2024
  3. 3National Bank, annual accounts 2018 and 2024

Acts, filings and financial milestones

2025
30-09
NBB filing Annual accounts filed
financial year 2024 · micro format · 61 days late
2024
31-12
Financial Weakest financial yearnet -€144,190
Net result drops to -€144,190, the lowest in the series.
20-11
NBB filing Annual accounts filed
financial year 2023 · micro format · 112 days late
19-09
Gazette deed Resignations: NIZET Jean Luc (director) and DESTREE Emmanuel Marie (director)
Registered-office move5 facts ▸
  • General meeting, 01-08-2024
  • Registered-office move, 4000 LIEGE,quai Banning,6
  • Director resignation, NIZET Jean Luc (director)
  • Director resignation, DESTREE Emmanuel Marie (director)
  • Other provision, “Belgian official gazette annexes header”, 24135902 (deed in French)
2023
31-12
Financial Liquidity more than doubledcurrent ratio 2.02
Current ratio from 0.95 to 2.02; short-term debt falls from €123,989 to €99,054.
11-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 11 days late
2022
30-09
NBB filing Annual accounts filed
financial year 2021 · micro format · 61 days late
2021
31-08
NBB filing Annual accounts filed
financial year 2020 · full format · 31 days late
2020
25-08
NBB filing Annual accounts filed
financial year 2019 · full format · 25 days late
2019
16-09
NBB filing Annual accounts filed
financial year 2018 · full format · 47 days late
2018
22-08
NBB filing Annual accounts filed
financial year 2017 · full format · 22 days late
2017
04-10
NBB filing Annual accounts filed
financial year 2016 · full format · 65 days late
2016
04-11
NBB filing Annual accounts filed
financial year 2015 · full format · 96 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 12 annual accounts filed, the latest 10 are here; all 12 are under Financials.
1 of 4 deeds read
About the unread acts

Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded27-03-2013
Financial year end31-12
Activities, NACEBEL 2025
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID 0208:0524896791
Registered 19-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 25 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2013
registered office establishment The establishment unit on the map
Ground area
6,847 m²
Building footprint
4,033 m²
Building volume
75,492 m³
Parcel 62814C0447/00E000, Wallonia · tallest building 29.5 m. Linked by address, not a title deed.
54 companies at this address See who is registered here
1 establishment unit
Quai Banning 6, 4000 Liège
Manufacture of basic pharmaceutical products and pharmaceutical preparations
since 2013unit no. 2.230.467.092
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
62814C0447/00E000 Wallonia 6,847 m² 1 · 4,033 m² 29.5 m · 7
How the parcels are linked
Good to know
The parcel matches the address exactly.